De novo malignancy after living donor liver transplantation: a large volume experience

ConclusionThe incidence of de novo malignancy was 1% at a median follow up of 42 (32-73) months. De novo malignancies following LDLT, although uncommon, are associated with significant mortality. A careful screening protocol should be followed post transplantation for early detection of de novo malignancies.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research